Financhill
Sell
38

PHAT Quote, Financials, Valuation and Earnings

Last price:
$17.54
Seasonality move :
-12.11%
Day range:
$17.36 - $17.74
52-week range:
$2.21 - $18.31
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.62x
P/B ratio:
--
Volume:
362.6K
Avg. volume:
922.3K
1-year change:
116.79%
Market cap:
$1.2B
Revenue:
$55.3M
EPS (TTM):
-$3.81

Earnings Data

Next earnings date for PHAT
Mar 05
2026
Most recent earnings per share
-$0.41
Beat by $0.01
(Oct 30/2025)
Consensus Estimate
-$0.42
(Oct 30/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PHAT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/05/2026 Q4 $56.2M -- -- -$0.20 --
10/30/2025 Q3 $47M $49.5M -$0.41 -$0.42 $0.01
08/07/2025 Q2 $35.6M $39.5M -$1.05 -$0.92 -$0.12
05/01/2025 Q1 $29M $28.5M -$1.31 -$1.07 -$0.24
03/06/2025 Q4 $25.7M $29.7M -$1.05 -$1.08 $0.03
11/07/2024 Q3 $12.4M $16.4M -$1.32 -$1.47 $0.14
08/08/2024 Q2 $5.7M $7.3M -$1.56 -$1.24 -$0.32
05/09/2024 Q1 $2.1M $1.9M -$1.42 -$1.22 -$0.20
03/07/2024 Q4 $379.2K $682K -$1.39 -$1.00 -$0.39
11/09/2023 Q3 -- -- -$0.76 -$0.97 $0.20
08/10/2023 Q2 -- -- -$0.84 -- --
05/10/2023 Q1 -- -- -$0.89 -- --
02/28/2023 Q4 -- -- -$1.33 -- --
11/08/2022 Q3 -- -- -$1.32 -- --
08/02/2022 Q2 -- -- -$1.33 -- --
05/10/2022 Q1 -- -- -$1.07 -- --
03/01/2022 Q4 -- -- -$0.95 -- --
11/08/2021 Q3 -- -- -$0.98 -- --
08/10/2021 Q2 -- -- -$1.00 -- --
05/11/2021 Q1 -- -- -$0.96 -- --
03/30/2021 Q4 -- -- -$1.58 -- --
11/10/2020 Q3 -- -- -$1.02 -- --
08/06/2020 Q2 -- -- -$0.64 -- --
05/12/2020 Q1 -- -- -$0.62 -- --
03/19/2020 Q4 -- -- -$3.96 -- --
11/25/2019 Q3 -- -- -$2.78 -- --
09/30/2018 Q3 -- -- -$0.01 -- --

Phathom Pharmaceuticals, Inc. Earnings Questions

  • How Much did Phathom Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Phathom Pharmaceuticals, Inc. reported $49.5M worth of top line sales in its most recent quarter.

  • Did Phathom Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Phathom Pharmaceuticals, Inc. announced earnings per share of -$0.41 which represents a beat of analyst forecast a -$0.42 per share.

  • Is Phathom Pharmaceuticals, Inc. Profitable?

    Phathom Pharmaceuticals, Inc. reported $43.3M that represents $0.59 per share over the last quarter.

  • What is the Analyst Consensus for Phathom Pharmaceuticals, Inc. EPS Next Year?

    Phathom Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$5.29 per share to -$2.34 per share next year representing a decrease of -55.7%.

  • When is Phathom Pharmaceuticals, Inc.'s Earnings Date?

    Phathom Pharmaceuticals, Inc.'s next earnings date is March 5, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 27

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Sell
20
SMX alert for Dec 27

SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.

Sell
11
CDNAF alert for Dec 27

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock